Last updated on May 2019

A Study of Two Dosing Schedules of Atezolizumab in Combination With Gemcitabine and Cisplatin as First-Line Treatment for Metastatic Bladder Cancer


Brief description of study

The purpose of this study is to compare any good and bad effects the study drug atezolizumab has on the cancer when combined with the standard chemotherapy drugs gemcitabine and cisplatin (or GC) in two different dosing schedules: chemotherapy (GC) before atezolizumab vs. GC after atezolizumab.

Clinical Study Identifier: NCT03093922

Find a site near you

Start Over

Memorial Sloan Kettering Commack

Commack, NY United States
7.02miles
  Connect »